ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,296 | -24.5% | 96,432 | -5.9% | 0.00% | – |
| Q2 2023 | $383,388 | -16.2% | 102,510 | -24.9% | 0.00% | – |
| Q1 2023 | $457,352 | -45.5% | 136,523 | -21.7% | 0.00% | – |
| Q4 2022 | $838,604 | +14.7% | 174,346 | +35.7% | 0.00% | – |
| Q3 2022 | $731,000 | +127.7% | 128,479 | +183.9% | 0.00% | – |
| Q2 2022 | $321,000 | +18.5% | 45,253 | +20.6% | 0.00% | – |
| Q1 2022 | $271,000 | -75.6% | 37,513 | -69.8% | 0.00% | – |
| Q4 2021 | $1,112,000 | -11.0% | 124,378 | +249.1% | 0.00% | – |
| Q3 2021 | $1,249,000 | -10.4% | 35,630 | -45.1% | 0.00% | – |
| Q2 2021 | $1,394,000 | -7.1% | 64,899 | +167.0% | 0.00% | – |
| Q1 2021 | $1,501,000 | +153.1% | 24,310 | +71.3% | 0.00% | – |
| Q4 2020 | $593,000 | – | 14,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |